Sarah Ibrahim Ahmed

Sarah Ibrahim Ahmed

Auto-generated profile, based on publicly available information

Sarah Ibrahim Ahmed

Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2018 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
LTLe Van Thanh
Le Van Thanh
MKMohamed Gomaa Kamel
Mohamed Gomaa Kamel
AGAhmed Abdelmotaleb Ghazy
Ahmed Abdelmotaleb Ghazy
AAAhmed M.A. Altibi
Ahmed M.A. Altibi
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

19 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SASarah Ibrahim Ahmed
Sarah Ibrahim Ahmed
AMAbeer Mohamed Mohy
Abeer Mohamed Mohy
HFHossam Mohamed Farid
Hossam Mohamed Farid
GEGhada Nabil Elnaggar
Ghada Nabil Elnaggar
Prostate cancer is a widespread malignancy with high mortality rates. Therapeutic success depends on clinical biomarkers for early detection and progression of the disease. The study aimed to assess the potential role of Thymidine Kinase one (TK1) and folate receptor alpha (FORα) in prostate cancer. Forty-five newly diagnosed prostate cancer patients, and 45 age matched apparently healthy males were included. Serum levels of TK1 and FORα were measured using enzyme-linked immunosorbent assay (ELISA) technique. TK1 and FORα were significantly increased in prostate cancer patients compared to the control group (mean 28.11pg/ml vs. 15.66 pg/ml, p-value < 0.001) and (median 1686.4 pg/ml vs. 437.2 pg/ml, p-value < 0.001) respectively. At a cutoff level ˃22.1 pg/ml, TK1 showed 91.11% sensitivity, 88.89% specificity and AUC = 0.973 (95% CI: 0.945–0.999). FORα showed moderate discriminatory power with 73.33% sensitivity and 88.89% specificity, AUC was 0.770 (95% CI: 0.661–0.879) at cutoff level ˃918.16 pg/ml. Combining TK1 with total PSA markedly improved the diagnostic accuracy (sensitivity 95.56%, specificity 97.78%). TK1 showed significant positive correlation with Gleason score, WHO grade and presence of metastasis at p < 0.001 each. TK1 & FORα could serve as biomarkers for prostate cancer diagnosis and prognosis offering a novel treatment approach.

24 August 2021 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Open access
PDF file
JZJuqian Zhang
Juqian Zhang
CZCan Zhou
Can Zhou
MIMahnoor Ihsan
Mahnoor Ihsan
ATAndreas Tsangarides
Andreas Tsangarides
SASarah Ahmed
Sarah Ahmed
RSRajiv Sankaranarayanan
Rajiv Sankaranarayanan
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of intravenous continuous infusion versus bolus injection of loop diuretics for the initial treatment of acute decompensated heart failure.